The Effect of Influenza Vaccination on the Systemic Inflammatory Response and Myocardial Protection in Patients Undergoing Cardiac Surgery: a Randomized Controlled Trial
NCT02565277 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2020-07-29
Summary
To assess the impact of influenza vaccination on the overall systemic inflammatory response in patients undergoing cardiac surgery and investigate functional and clinical outcomes in vaccinated patients postoperatively.
Conditions
- Systemic Inflammatory Response
Interventions
- BIOLOGICAL
- DRUG
Sponsors & Collaborators
-
Health Sciences North Research Institute
lead OTHER
Principal Investigators
-
Roni Atoui, MSc MD FRCSC · Health Sciences North Research Institute
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-09-30
- Primary Completion
- 2018-12-25
- Completion
- 2018-12-25
Countries
- Canada
Study Locations
More Related Trials
-
Do Some Healthy Adults Consistently Have Systemic Reactions to Influenza Vaccines?
NCT02263027 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Elderly Subjects
NCT00329927 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to Elderly Subjects
NCT00522236 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases
NCT00607178 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Protection From Influenza: Determining the Impact of Prior Infection
NCT03004040 ·Status: UNKNOWN
-
A Study of Ad26.COV2.S and Influenza Vaccines in Healthy Adults
NCT05091307 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older
NCT00329966 ·Status: COMPLETED ·Phase: PHASE2
-
Timing of Influenza Vaccination in Patients With Heart Failure
NCT05507502 ·Status: UNKNOWN ·Phase: NA
-
Support Annual Strain Update, Safety and Immunogenicity of an Inactivated, Adjuvanted Influenza Vaccine, Formulation 2007-2008, When Administered to Subjects 18-64 Years Affected by Chronic Diseases.
NCT00522067 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of H1N1 Influenza Vaccines in Manitoba, Canada
NCT01622491 ·Status: UNKNOWN
-
Influenza Vaccination and Oral Anticoagulant Therapy
NCT00222638 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity and Safety of a Vaccine Against Influenza (2010-2011 Northern Hemisphere Season, Intradermal Route)
NCT01138397 ·Status: COMPLETED ·Phase: PHASE3
-
Hutterite Influenza Prevention Study
NCT00877396 ·Status: COMPLETED ·Phase: PHASE4
-
Influenza Vaccine Challenge Study in Healthy Subjects
NCT01226758 ·Status: COMPLETED ·Phase: PHASE1
-
Immune Response Study of Influenza Vaccine
NCT01310374 ·Status: COMPLETED
-
Safety, Tolerability, Efficacy and Immunogenicity of an Influenza A Vaccine (FP-01.1) in Healthy Volunteers Following Virus Challenge
NCT02071329 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase 1, Open Label, Ascending Dose Cohort Study of the Pharmacokinetics of Anti-Influenza Hyperimmune Intravenous Immunoglobulin in Healthy Subjects
NCT02037282 ·Status: WITHDRAWN ·Phase: PHASE1
-
Study of Immune Responses to Influenza Vaccination
NCT03346772 ·Status: RECRUITING ·Phase: PHASE4
-
Revealing Protective Immunity to Influenza Using Systems Immunology
NCT06501963 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to NON Elderly AND Elderly Subjects
NCT00518726 ·Status: COMPLETED ·Phase: PHASE2
-
Does Seasonal Influenza Vaccination Affect the Incidence of pH1N1 Influenza?
NCT01001325 ·Status: COMPLETED ·Phase: PHASE3
-
Studying Cell Immune Responses to a Live Flu Vaccine in Healthy Adults
NCT01730144 ·Status: COMPLETED
-
A Digital Flu Intervention for People With Cardiovascular Conditions
NCT04584645 ·Status: COMPLETED ·Phase: NA
-
Immunogenicity and Safety Study of an Investigational Influenza (H1N1 Influenza Virus) Vaccine in Adults
NCT00989287 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine in Healthy Adult Subjects
NCT00845429 ·Status: COMPLETED ·Phase: PHASE2